MedPath

The effect of dyspepsia and reflux treatment on the number and severity of migraine headache attacks

Phase 3
Conditions
Migraine.
Migraine
Registration Number
IRCT20190618043934N28
Lead Sponsor
Birjand University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
60
Inclusion Criteria

Having informed consent to participate in the study
Age 18 to 60 years

Exclusion Criteria

History of drug use
Psychotic disorder
Contraindications for drug administration
Under treatment for constipation
Under the treatment of peptic ulcer Drug
sensitivity to drugs related to the treatment of digestive disorders

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath